Experimental Alzheimer's drug Solanezumab fails in large trial
Thursday, November 24, 2016 - 10:01
in Health & Medicine
Ed AdamczykINDIANAPOLIS, Nov. 24 (UPI) -- Solanezumab, a promising experimental drug to treat Alzheimer's disease, failed in large trials, the Eli Lilly pharmaceutical company said.